Study Details

Back to Search Results

A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects with Fibromyalgia

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT03092726

Astellas Study ID

The unique identification code given by the study sponsor.

8062-CL-0101

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

N/A

Follow Trial

Condition

Fibromyalgia

Phase

These clinical trials are done to learn if an experimental treatment helps participants who have a specific condition or disease. Phase 2 trials usually include a larger group of participants than Phase 1 trials.

Phase 2

Age

18 years - 80 years

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

May 2017 - Mar 2018

Masking

Double (Participant, Investigator)

Enrollment number

183

A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects with Fibromyalgia

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects with Fibromyalgia? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Summit Research Network

Portland, United States, 97210

Omega Medical Research

Warwick, United States, 02886

Collaborative Neuroscience Network, LLC.

Torrance, United States, 90502

The Center For Pharmaceutical Research

Kansas City, United States, 64114

Meridian Clinical Research

Dakota Dunes, United States, 57049

Chicago Research Center, Inc

Chicago, United States, 60634

ClinSearch, LLC

Chattanooga, United States, 37421

Medisphere Medical Research Center, LLC

Evansville, United States, 47714

Elite Clinical Research, LLC

Jackson, United States, 39202

Infinity Medical Research, Inc

North Dartmouth, United States, 02747

University of Cincinnati

Cincinnati, United States, 45219

PAB Clinical Research

Brandon, United States, 33511

Private Practice

Raleigh, United States, 27609

Neuro-Behavioral Clinical Research, Inc

Canton, United States, 44718

Avail Clinical Research, LLC

Deland, United States, 32720

PMG of Winston-Salem, LLC

Winston-Salem, United States, 27103

Lehigh Center for Clinical Research

Allentown, United States, 18104

Neurobehavioral Research, Inc

Cedarhurst, United States, 11516

Associated Neurologists of Southern Connecticut, PC

Fairfield, United States, 06824

NY Scientific

Brooklyn, United States, 11235

Clinical Investigation Specialists, Inc

Kenosha, United States, 53142

Clinical Neuroscience Solutions, Inc

Orlando, United States, 32801

Noesis Pharma, LLC

Phoenix, United States, 85032

Advanced Biomedical Research of America

Las Vegas, United States, 89123

Excell Research, Inc

Oceanside, United States, 92056

The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website

© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.

POWERED BY:

Pharma Intelligence logo